Status | Study |
Available |
Study Name: Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies Condition: Neoplasm Desmoid Tumor Date: 2016-11-02 Interventions: Drug: PF-03084014 Two patients enrolled in this study will continue receiving 80mg BID doses of PF-03084 |
Recruiting |
Study Name: National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) Condition: Aggressive Fibromatosis Date: 2016-07-15 Interventions: Procedure: biopsy pre-therapeu |
Recruiting |
Study Name: Optional Sub-study to Intraoperative Imaging With ICG Registry Condition: Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Date: 2016-01-06 Interventions: Other: data collection |
Active, not recruiting |
Study Name: A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) Condition: Fibromatosis Date: 2015-07-08 Interventions: Drug: Imatinib Imatinib 400 mg/day until disease progression |
Recruiting |
Study Name: Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment Condition: Desmoid Tumors Date: 2015-06-04 Interventions: Device: "cryoprobes" Patient undergo percutaneous cryoablation of desmoid tumor, with cryoprob |
Recruiting |
Study Name: 18F-FES PET/CT in Imaging Patients With Desmoid Tumors Condition: Deep Fibromatosis/Desmoid Tumor Fa Date: 2015-02-16 Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol |
Active, not recruiting |
Study Name: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Condition: Desmoid Type-fibromatosis Date: 2015-01-28 Interventions: Drug: Toremifene Patients will receive 60 mg daily and then 180 daily in case of progression |
Recruiting |
Study Name: Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients Condition: Desmoid-type Fibromatosis Date: 2015-01-28 Interventions: Other: Observational approach Patients will be placed under wait and see approach without any specific t |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Condition: Desmoid-Type Fibromatosis Date: 2014-02-17 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Condition: Desmoid Tumors Aggressive Fibromatosis Date: 2013-10-31 Interventions: Drug: PF-03084014 Treatment with the selective small-molecule >=-secretase inhibitor PF- 3084014 caus |